ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

CLINICAL AND LABORATORY PECULIARITIES OF COMBINED CLINICAL COURSE OF METABOLIC AND ARTICULAR SYNDROMES

Journal: I.P. Pavlov Russian Medical Biological Herald (Vol.26, No. 2)

Publication Date:

Authors : ;

Page : 229-237

Keywords : metabolic syndrome; articular syndrome; comorbidity; rheumatic diseases;

Source : Downloadexternal Find it from : Google Scholarexternal

Abstract

Aim. To identify clinical and laboratory peculiarities of a combined clinical course of metabolic and articular syndromes. Materials and Methods. In the research 126 individuals participated. They were arranged into 3 groups: the 1st group included 46 patients with comorbid pathology, the 2nd group – 44 patients with metabolic syndrome, and the 3d group – 36 patients with articular syndrome. The following parameters were evaluated: anthropometric data (height, body mass, body mass index, waist circumference), lipid spectrum, glycohemoglobin, nonspecific markers of inflammation, daily profile of arterial pressure. Results. In the group with comorbid pathology higher average values of body mass were recorded – 115.8 [60;140] kg in comparison with the 2nd and 3d groups – 93.5 [72;130] and 71.5 [58;98] kg, respectively; erythrocyte sedimentation rate – 18.3 [5;34] mm/h was reliably higher than in the 2nd group (11.5 [2;24] mm/h), and median cholesterol (6.18 [5,39;6,85] mmol/L) was higher than in the 3d group (4.82 [3,48;5,61] mmol/L). In the 1st and 2nd groups higher average values of systolic arterial pressure were recorded in comparison with the 3d group – 158,5 [120;190]; 154,6 [115;190] and 126,4 [96;168] mm Hg, respectively. Conclusions. In patients with combined metabolic and articular syndromes higher values of body mass and systolic arterial pressure were identified. Based on the laboratory findings, parameters of cholesterol and erythrocyte sedimentation rate were higher in patients with comorbid condition than in those with the isolated pathologies.

Last modified: 2019-01-09 16:08:14